|
Volumn 5, Issue 1, 1996, Pages 17-27
|
Lansoprazole: A new proton pump inhibitor for the treatment of peptic ulceration and reflux oesophagitis
|
Author keywords
Acid peptic disorders; Amoxycillin; Antibiotics; Antisecretory drugs; Carcinoids; Cimetidine; Clarithromycin; Duodenal ulcer; Famotidine; Gastric acid; Gastric ulcer; Healing; Helicobacter pylori; Histamine H2 receptor antagonists; Lansoprazole; Nizatidine; Omeprazole; Pantoprazole; Pepsin; Peptic ulcer; Proton pump inhibitors; Rabeprazole; Ranitidine; Reflux oesophagitis; Relapse; Resistant ulcer; Zollinger Ellison
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
CIMETIDINE;
CLARITHROMYCIN;
DIMAPRIT;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
NEW DRUG;
NIZATIDINE;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP;
PROTON PUMP INHIBITOR;
RABEPRAZOLE;
RANITIDINE;
ANALGESIA;
ANIMAL MODEL;
CLINICAL TRIAL;
DIARRHEA;
DRUG CHOICE;
DRUG MECHANISM;
DUODENUM ULCER;
HEADACHE;
HELICOBACTER PYLORI;
HUMAN;
MARKETING;
NAUSEA;
NONHUMAN;
PEPTIC ULCER;
PRESCRIPTION;
REFLUX ESOPHAGITIS;
REVIEW;
STOMACH ACID SECRETION;
STOMACH ULCER;
ULCER HEALING;
ZOLLINGER ELLISON SYNDROME;
|
EID: 0030033880
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.1.17 Document Type: Review |
Times cited : (1)
|
References (0)
|